Related Experiment Video
Updated: Jun 17, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Superior vena cava syndrome as tumour presentation
Nuno Filipe Pires1, António Morais, Henrique Queiroga
1Serviço de Pneumologia, Hospital S. João, Alameda Prof. Hernâni Monteiro, 4202 -451 Porto. nunofxpires@gmail.com
Revista Portuguesa De Pneumologia
|January 8, 2010
Summary
Superior vena cava syndrome (SVCS) is often caused by lung cancer. Small-cell lung cancer (SCLC), smoking, and metastasis are linked to poorer survival in SVCS patients.
Area of Science:
- Oncology
- Thoracic Medicine
Background:
- Superior vena cava syndrome (SVCS) results from superior vena cava (SVC) compression, often indicating malignancy.
- Common symptoms include neck and chest swelling, facial plethora, and edema.
Purpose of the Study:
- To analyze patient demographics, tumor characteristics, and prognostic factors in SVCS cases without prior diagnosis.
- To identify factors influencing survival in patients presenting with SVCS.
Main Methods:
- Retrospective analysis of 60 SVCS patients admitted between January 1995 and December 2006.
- Data collection included patient demographics, smoking habits, performance status, tumor histology, staging, treatment, and survival.
Main Results:
- Lung cancer was diagnosed in 87% of patients, with small-cell lung cancer (SCLC) being the most frequent type (41%).
- Non-Hodgkin's lymphoma was diagnosed in 10% of cases.
- Favorable prognostic factors for survival included absence of metastasis, lymphoma histology, good performance status, and non-smoker status. SCLC was associated with worse survival.
Conclusions:
- Small-cell lung cancer (SCLC), smoking, poor performance status, and metastatic disease are unfavorable prognostic factors for SVCS.
- Early diagnosis and appropriate treatment considering these factors are crucial for improving patient outcomes.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...